Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far.
Ital J Pediatr
; 46(1): 56, 2020 Apr 29.
Article
in English
| MEDLINE | ID: covidwho-141543
ABSTRACT
Recently, an outbreak of viral pneumonitis in Wuhan, Hubei, China successively spread as a global pandemia, led to the identification of a novel betacoronavirus species, the 2019 novel coronavirus, successively designated 2019-nCoV then SARS-CoV-2). The SARS-CoV-2 causes a clinical syndrome designated coronavirus disease 2019 (COVID19) with a spectrum of manifestations ranging from mild upper respiratory tract infection to severe pneumonitis, acute respiratory distress syndrome (ARDS) and death. Few cases have been observed in children and adolescents who seem to have a more favorable clinical course than other age groups, and even fewer in newborn babies. This review provides an overview of the knowledge on SARS-CoV-2 epidemiology, transmission, the associated clinical presentation and outcomes in newborns and infants up to 6 months of life.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Coronavirus Infections
/
Pandemics
/
Betacoronavirus
Type of study:
Experimental Studies
/
Observational study
/
Prognostic study
/
Randomized controlled trials
Limits:
Humans
/
Infant
/
Infant, Newborn
Language:
English
Journal:
Ital J Pediatr
Journal subject:
Pediatrics
Year:
2020
Document Type:
Article
Affiliation country:
S13052-020-0820-x
Similar
MEDLINE
...
LILACS
LIS